Eliglustat medication period of performance: 10/1/2020 to 9/30/2021
Ended Awarded Last action
- Contract number
- 36C26221N0039
- Awardee
-
Genzyme Corporation UEI X2XMAQLR9DA8
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $265,045
Award facts
- Contract value 100% obligated
- $265,045.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Deerfield, IL 60015, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $44,051 | |
| Original award | $220,994 |
About this award
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $265,045.04 firm fixed price delivery order to Genzyme Corporation, doing business under its Genzyme Therapeutics Division, for eliglustat medication. The period of performance is from October 1, 2020 to September 30, 2021. The delivery order was awarded against Genzyme Corporation's Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with performance taking place in Riverwoods, Illinois. No set-aside designation was used for this contract award to supply eliglustat medication to VHA networks in the region over the one year ordering period.
Quick answers
Who was awarded contract 36C26221N0039?
36C26221N0039 was awarded to Genzyme Corporation by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 1, 2020.
How much is contract 36C26221N0039 worth?
The government has obligated $265,045 on 36C26221N0039.
Is contract 36C26221N0039 an order under another contract?
Yes. 36C26221N0039 is a delivery order under 36F79719D0153, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26221N0039 competed?
The extent of competition for 36C26221N0039 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award